Proprio’s Series B funding round was recently featured in GeekWire, in an article entitled, “Fresh off FDA milestone, Proprio lands $43M as it readies surgical navigation tech.”
The article highlights Proprio's key milestones from the past 6 months and discusses what our team hopes to accomplish through the end of the year.
“Paradigm has been used in surgeries with select hospital systems to collect data during development. The company received 510(k) clearance in April, demonstrating that its technology is safe and effective. Proprio is now preparing Paradigm for human use in live cases this summer.”
Read the full article here.
Learn more about our surgical technology at Proprio here.
.svg)
.svg)
